Systematic Financial Management LP Sells 57,628 Shares of Sabra Healthcare REIT, Inc. $SBRA

Systematic Financial Management LP reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.6% during the first quarter, Holdings Channel.com reports. The fund owned 2,154,881 shares of the real estate investment trust’s stock after selling 57,628 shares during the period. Sabra Healthcare REIT makes up about 1.0% of Systematic Financial Management LP’s portfolio, making the stock its 28th biggest position. Systematic Financial Management LP’s holdings in Sabra Healthcare REIT were worth $41,438,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Focus Partners Wealth increased its position in Sabra Healthcare REIT by 11.4% during the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Sabra Healthcare REIT by 150.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,536 shares during the last quarter. First Trust Advisors LP lifted its position in shares of Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after purchasing an additional 78,709 shares during the period. Cerity Partners LLC lifted its position in shares of Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock worth $345,000 after purchasing an additional 7,885 shares during the period. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after purchasing an additional 2,557 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on SBRA. Cantor Fitzgerald increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Citizens Jmp boosted their target price on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Wells Fargo & Company upped their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.25.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $22.03 on Friday. The stock has a market capitalization of $5.56 billion, a price-to-earnings ratio of 34.97, a PEG ratio of 1.63 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $22.55. The stock’s 50 day moving average price is $19.64 and its two-hundred day moving average price is $19.82. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s quarterly revenue was up 20.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.4%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.